AL TIME NET WORTH
$10B
as of 9/3/18
2018 KOREA’S 50 RICHEST NET WORTH
$11B
as of 6/6/18
Seo Jung-jin is CEO of Celltrion, a biopharmaceutical company which develops drugs to treat cancer, influenza and rheumatoid arthritis, among others.
He cofounded the company in 2002 and took it public in 2008.
With expectations for biosimilar drugs high in South Korea, his Celltrion has become a favorite among investors.
His marketing subsidiary, Celltrion Healthcare, saw a favorable initial public offering in July 2017.
In 2018 he catapulted to the No. 2 spot of the richest Koreans as shares in Celltrion soared after three of its drugs expanded market share.
STATS
AGE:60
SOURCE OF WEALTH:biotech, Self Made
RESIDENCE:Seoul, South Korea
CITIZENSHIP:South Korea
MARITAL STATUS:Married
CHILDREN:2
EDUCATION: Bachelor of Arts/Science, Konkuk University; Master of Science, Konkuk University